Publications by authors named "Aimee Dallob"

Claim this Profile
H
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, Andy Liaw, Matt Wiener, Aimee Dallob

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Jeffrey L Seeburger, Daniel J Holder, Marc Combrinck, Catharine Joachim, Omar Laterza, Aimee Dallob

J Alzheimers Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Aimee Dallob, Wen-Lin Luo, Julie Mabalot Luk, Lisa Ratcliffe, Amy O Johnson-Levonas

Platelets· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects.
Eseng Lai, Jules I Schwartz, Aimee Dallob, Patricia Jumes, Fang Liu

Platelets· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.
Jonathan H Williams, Gordon K Wilcock, Jeffrey Seeburger, Aimee Dallob, Omar Laterza

Alzheimers Res Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20.
Arnaldo M Pica-Mendez, Michael Tanen, Aimee Dallob, Wesley Tanaka, Omar F Laterza

Clin Chim Acta· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.
Jules I Schwartz, Aimee L Dallob, Patrick J Larson, Omar F Laterza, Jutta Miller

J Clin Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
Aimee Dallob, Christopher J Hawkey, Howard Greenberg, Nicholas Wight, Paul De Schepper

J Clin Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis